Aptus_logo_blue.jpg

With a commitment to improving the prognosis of heart valve diseases, Aptus Bioreactors provides novel bioreactor systems and accessories capable of creating and testing living, patient-specific, tissue engineered heart valves (TEHVs). Using the TEHVs, we envision “One Surgery, for Life” where hospital costs, risks, and other burdens associated with heart valve disease are eliminated.

Please join us in making this a reality!

 

Featured Technology